Biochemical Engineering Poster Winners at ECI Conference
13 November 2024
Congratulations to UCL Biochemical Engineering Researchers Marie Dorn (left) and Delphine Tavernier (right) who won Best Poster awards at the recent ECI Integrated Continuous Biomanufacturing (ICB) conference.
The ECI Integrated Continuous Biomanufacturing (ICB) conference aims to unite industry and academia to foster collaboration and enhance patient access to transformative therapies. This year’s (ICB VI) motto, "Small Steps, Big Leaps," reflected the focus on incremental advancements that lead to significant breakthroughs.
ICB VI showcased the exciting progress in continuous bioprocessing over the past decade, presenting real-world examples of these technologies in good manufacturing practices (GMP). The program addressed various topics, including regulatory issues, process simplification, applicability to new modalities, and technological advancements in process monitoring and control. Building on the success of previous conferences, ICB VI sought to inspire further innovation in the biomanufacturing field.
Research initiatives taking place in the UCL Biochemical Engineering Department highlight the value of small, incremental improvements in achieving major advancements. Delphine Tavernier presented a poster on "Cell Retention Investigations at Different Development Scales to Inform Perfusion Scale-Up, Operation, and Impact on Downstream Processing," while Marie Dorn showcased her work on "Early Manufacturing Insights and Clone Selection for Perfusion Processes." Both researchers were honoured with Best Poster Prizes at the conference. Their contributions underscore UCL’s commitment to optimising bioprocesses through innovative engineering solutions and continuous methods to enhance efficiency and scalability.
"Winning the Best Poster Prize for my work on “Cell Retention Investigations at Different Development Scales to Inform Perfusion Scale-Up, Operation, and Impact on Downstream Processing” is a great honour. This recognition showcases the impact of our work done here at UCL on advancing the scale-up and operation of perfusion systems, and in my case, specifically optimising cell retention devices and filter performance for more reliable and efficient monoclonal antibodies production. I hope these findings can play a small part in advancing continuous manufacturing, and I’m excited to keep learning and contributing to this important area of research." Delphine Tavernier, November 2024
Find out more
- 2024 ECI Integrated Continuous Biomanufacturing (ICB) conference
- Marie Dorn's UCL Research Profile
- Delphine Tavernier's UCL Research Profile